from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0776c/-

LFCtreatmentdescriptionclass of inhibitor

0.260

Amikacinug/mL Amikacintranslation

0.119

Cap5-10ug/mL Capreomycintranslation

0.719

Rox10-50 ug/mL Roxithromycintranslation

-0.107

SM2-5 ug/mL Streptomycintranslation

1.395

Tet5-10 ug/mL Tetracyclinetranslation

0.674

Rif0.2-5ug/mL Rifampicintranscription

0.619

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.233

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.412

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.542

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.029

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.591

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.152

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.418

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.389

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.573

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.880

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.127

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.807

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.252

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.660

KCN5-20 ug/mL Potassium cyaniderespiration

2.304

NaN30.2-2 mM Sodium aziderespiration

-0.531

Nigericin50 uM Nigericinrespiration

0.203

TRC10-150 ug/mL Triclosanrespiration

1.062

TRZ10-25 ug/mL Thioridazinerespiration

-0.232

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.427

menadione6-10 ug/mL Menadionerespiration

0.448

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.153

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.112

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.123

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.876

NRP_1Non-replicating persistence stage 1dosRassociated

-0.650

Amp0.2mg/mL AmpicillincellWall

-0.684

Cephalexin20-100 ug/mL CephalexincellWall

0.189

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.728

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.443

EMB10-20 ug/mL EthambutolcellWall

-0.393

Eta12-40 ug/mL EthionamidecellWall

-0.605

INH0.2-0.4 ug/mL IsoniazidcellWall

0.051

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.984

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.046

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.046

BZA0.12 mg/mL BenzamidearomaticAmides

-0.085

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.175

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.213

H2O24 mM hydrogen peroxideDNAdamaging

0.160

Levo10 ug/mL LevofloxacinDNAdamaging

-0.273

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.442

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.419

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.083

UVUV-irradiationDNAdamaging

1.011

ARP41-4 ug/mL Antitubercular compound ARP4?

0.070

Antimycin12.5-50 ug/mL Antimycin A?

-0.653

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.136

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.340

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.106

PA8240.2-2 ug/mL PA-824?

-0.211

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.006

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.458

Verapamil50 uM Verapamil?

0.455

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.937

methoxatin10-20 ug/mL Methoxatin?